Capricor Therapeutics Inc Sustainability Reports
Capricor Therapeutics, Inc. is a biotechnology company focused on the development of transformative cell and exosome-based therapeutics. The company primarily targets diseases with high unmet medical needs, such as Duchenne muscular dystrophy.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493002ZI5PDLXV4DX14
FIGI: BBG001SKJV12
7 reports from 2013 to 2025
